{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T16:41:45Z","timestamp":1788885705998,"version":"build-2803163510"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:00:00Z","timestamp":1585180800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1007\/s40263-020-00720-w","type":"journal-article","created":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T18:04:20Z","timestamp":1585245860000},"page":"545-553","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Efficacy, Tolerability, and Safety of Concentrated Intranasal Midazolam Spray as Emergency Medication in Epilepsy Patients During Video-EEG Monitoring"],"prefix":"10.1007","volume":"34","author":[{"given":"Anemone","family":"von Blomberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lara","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Knake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Fuest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann Philipp","family":"Z\u00f6llner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp S.","family":"Reif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00dcmniye","family":"Balaban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Schubert-Bast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Rosenow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Strzelczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,26]]},"reference":[{"issue":"2","key":"720_CR1","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.annemergmed.2003.10.045","volume":"43","author":"Emergency Physicians","year":"2004","unstructured":"Physicians Emergency, Committee Policies. Clinical policies subcommittee. Clinical policy. Ann Emerg Med. 2004;43(2):278\u201390. https:\/\/doi.org\/10.1016\/j.annemergmed.2003.10.045.","journal-title":"Ann Emerg Med."},{"issue":"14","key":"720_CR2","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1056\/NEJM199804023381407","volume":"338","author":"H Daniel","year":"1998","unstructured":"Daniel H, Lowenstein M, Alldredge B. Status epilepticus. New Engl J Med. 1998;338(14):970\u20136.","journal-title":"New Engl J Med."},{"issue":"4","key":"720_CR3","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1007\/s11910-011-0207-x","volume":"11","author":"VS Poukas","year":"2011","unstructured":"Poukas VS, Pollard JR, Anderson CT. Rescue therapies for seizures. Curr Neurol Neurosci Rep. 2011;11(4):418\u201322. https:\/\/doi.org\/10.1007\/s11910-011-0207-x.","journal-title":"Curr Neurol Neurosci Rep."},{"key":"720_CR4","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1111\/epi.13837","volume":"58","author":"A Strzelczyk","year":"2017","unstructured":"Strzelczyk A, Ansorge S, Hapfelmeier J, Bonthapally V, Erder MH, Rosenow F. Costs, length of stay, and mortality of super-refractory status epilepticus: A population-based study from Germany. Epilepsia. 2017;58:1533\u201341. https:\/\/doi.org\/10.1111\/epi.13837.","journal-title":"Epilepsia."},{"key":"720_CR5","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1111\/epi.14729","volume":"60","author":"S Schubert-Bast","year":"2019","unstructured":"Schubert-Bast S, Z\u00f6llner JP, Ansorge S, et al. Burden and epidemiology of status epilepticus in infants, children, and adolescents: A population-based study on German health insurance data. Epilepsia. 2019;60:911\u201320. https:\/\/doi.org\/10.1111\/epi.14729.","journal-title":"Epilepsia."},{"issue":"2","key":"720_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.5863\/1551-6776-18.2.79","volume":"18","author":"LK Humphries","year":"2013","unstructured":"Humphries LK, Eiland LS. Treatment of acute seizures: is intranasal midazolam a viable option? J Pediatr Pharmacol Ther. 2013;18(2):79\u201387. https:\/\/doi.org\/10.5863\/1551-6776-18.2.79.","journal-title":"J Pediatr Pharmacol Ther."},{"issue":"6","key":"720_CR7","doi-asserted-by":"publisher","first-page":"409","DOI":"10.2165\/00003088-199936060-00003","volume":"36","author":"R Elisabeth","year":"1999","unstructured":"Elisabeth R, Tr\u00e9luyer JM, Pons G. Pharmacokinetic optimisation of benzodiazepine therapy for acute seizures. Focus on delivery routes. Clin Pharmacokinet. 1999;36(6):409\u201324. https:\/\/doi.org\/10.2165\/00003088-199936060-00003.","journal-title":"Clin Pharmacokinet"},{"issue":"10","key":"720_CR8","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.addr.2012.01.017","volume":"64","author":"GD Anderson","year":"2012","unstructured":"Anderson GD, Saneto RP. Current oral and non-oral routes of antiepileptic drug delivery. Adv Drug Deliv Rev. 2012;64(10):911\u20138. https:\/\/doi.org\/10.1016\/j.addr.2012.01.017.","journal-title":"Adv Drug Deliv Rev"},{"key":"720_CR9","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/S0140-6736(05)66909-7","volume":"366","author":"J McIntyre","year":"2005","unstructured":"McIntyre J, Norris E, Appleton R, et al. Safety and efficacy of buccal midazolam versus rectal diazepam for emergency treatment of seizures in children: a randomised controlled trial. Lancet. 2005;366:205\u201310.","journal-title":"Lancet"},{"issue":"3","key":"720_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/emj.4.3.169","volume":"4","author":"GM Galvin","year":"1987","unstructured":"Galvin GM, Jelinek GA. Midazolam: an effective intravenous agent for seizure control. Arch Emerg Med. 1987;4(3):169\u201372. https:\/\/doi.org\/10.1136\/emj.4.3.169.","journal-title":"Arch Emerg Med."},{"issue":"8","key":"720_CR11","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s40263-018-0544-2","volume":"32","author":"J Kadel","year":"2018","unstructured":"Kadel J, Bauer S, Hermsen AM, et al. Use of emergency medication in adult patients with epilepsy: a multicentre cohort study from Germany. CNS Drugs. 2018;32(8):771\u201381. https:\/\/doi.org\/10.1007\/s40263-018-0544-2.","journal-title":"CNS Drugs"},{"key":"720_CR12","doi-asserted-by":"crossref","unstructured":"Kapur J, Macdonald RL. Rapid seizure-induced reduction of benzodiazepine and Zn2+\u2009sensitivity of hippocampal dentate granule cell GABAA receptors. J Neurosci. 1997;17(19):7532\u20137540. http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9295398%0A\nhttp:\/\/www.pubmedcentral.nih.gov\/articlerender.fcgi?artid=PMC2892718.","DOI":"10.1523\/JNEUROSCI.17-19-07532.1997"},{"issue":"3","key":"720_CR13","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1111\/j.1528-1157.1998.tb01375.x","volume":"39","author":"RC Scott","year":"1998","unstructured":"Scott RC, Besag FMC, Boyd SG, Berry D, Neville BGR. Buccal absorption of midazolam: pharmacokinetics and EEG pharmacodynamics. Epilepsia. 1998;39(3):290\u20134.","journal-title":"Epilepsia."},{"issue":"5","key":"720_CR14","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.pediatrneurol.2005.09.006","volume":"34","author":"M Bhattacharyya","year":"2006","unstructured":"Bhattacharyya M, Kalra V, Gulati S. Intranasal midazolam vs rectal diazepam in acute childhood seizures. Pediatr Neurol. 2006;34(5):355\u20139. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2005.09.006.","journal-title":"Pediatr Neurol"},{"issue":"2","key":"720_CR15","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s00415-012-6659-3","volume":"260","author":"A Thakker","year":"2013","unstructured":"Thakker A, Shanbag P. A randomized controlled trial of intranasal-midazolam versus intravenous-diazepam for acute childhood seizures. J Neurol. 2013;260(2):470\u20134. https:\/\/doi.org\/10.1007\/s00415-012-6659-3.","journal-title":"J Neurol"},{"issue":"2","key":"720_CR16","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1177\/088307380201700206","volume":"17","author":"T Fi\u015fgin","year":"2002","unstructured":"Fi\u015fgin T, Gurer Y, Tezic T, et al. Effects of intranasal midazolam and rectal diazepam on acute convulsions in children: prospective randomized study. J Child Neurol. 2002;17(2):123\u20136. https:\/\/doi.org\/10.1177\/088307380201700206.","journal-title":"J Child Neurol"},{"issue":"9","key":"720_CR17","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1111\/epi.13088","volume":"56","author":"L Kay","year":"2015","unstructured":"Kay L, Reif PS, Belke M, et al. Intranasal midazolam during presurgical epilepsy monitoring is well tolerated, delays seizure recurrence, and protects from generalized tonic\u2013clonic seizures. Epilepsia. 2015;56(9):1408\u201314. https:\/\/doi.org\/10.1111\/epi.13088.","journal-title":"Epilepsia."},{"issue":"3","key":"720_CR18","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1097\/PEC.0b013e3180328c92","volume":"23","author":"M Holsti","year":"2007","unstructured":"Holsti M, Sill BL, Firth SD, Filloux FM, Joyce SM, Furnival RA. Prehospital intranasal midazolam for the treatment of pediatric seizures. Pediatr Emerg Care. 2007;23(3):148\u201353. https:\/\/doi.org\/10.1097\/PEC.0b013e3180328c92.","journal-title":"Pediatr Emerg Care"},{"key":"720_CR19","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1002\/acn3.50932","volume":"6","author":"L Kay","year":"2019","unstructured":"Kay L, Merkel N, Von Blomberg A, et al. Intranasal midazolam as first-line in-hospital treatment for status epilepticus: a pharmaco-EEG cohort study. Ann Clin Transl Neurol. 2019;6:2413\u201325. https:\/\/doi.org\/10.1002\/acn3.50932.","journal-title":"Ann Clin Transl Neurol."},{"issue":"8","key":"720_CR20","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1001\/archpediatrics.2010.130","volume":"164","author":"M Holsti","year":"2010","unstructured":"Holsti M, Dudley N, Schunk J, et al. Intranasal midazolam vs rectal diazepam for the home treatment of acute seizures in pediatric patients with epilepsy. Arch Pediatr Adolesc Med. 2010;164(8):747\u201353. https:\/\/doi.org\/10.1001\/archpediatrics.2010.130.","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"720_CR21","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/j.1553-2712.2010.00751.x","volume":"17","author":"J McMullan","year":"2010","unstructured":"McMullan J, Sasson C, Pancioli A, Silbergleit R. Midazolam versus Diazepam for the treatment of status Epilepticus in children and young adults: a meta-analysis. Acad Emerg Med. 2010;17(6):575\u201382. https:\/\/doi.org\/10.1111\/j.1553-2712.2010.00751.x.","journal-title":"Acad Emerg Med"},{"issue":"9\u201310","key":"720_CR22","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1111\/j.1440-1754.2004.00463.x","volume":"40","author":"MG Harbord","year":"2004","unstructured":"Harbord MG, Kyrkou NE, Kay D, Coulthard KP. Use of intranasal midazolam to treat acute seizures in paediatric community settings. J Paediatr Child Health. 2004;40(9\u201310):556\u20138.","journal-title":"J Paediatr Child Health"},{"issue":"7","key":"720_CR23","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1586\/14737175.2014.925398","volume":"14","author":"M Mula","year":"2014","unstructured":"Mula M. The safety and tolerability of intranasal midazolam in epilepsy. Expert Rev Neurother. 2014;14(7):735\u201340.","journal-title":"Expert Rev Neurother"},{"issue":"7253","key":"720_CR24","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1136\/bmj.321.7253.83","volume":"321","author":"E Lahat","year":"2000","unstructured":"Lahat E, et al. Comparison of intranasal midazolam with intravenous diazepam for treating febrile seizures in children: prospective randomised study. BMJ. 2000;321(7253):83\u20136. https:\/\/doi.org\/10.1136\/bmj.321.7253.83.","journal-title":"BMJ"},{"issue":"2","key":"720_CR25","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/0013-4694(58)90053-1","volume":"10","author":"GH Klem","year":"1999","unstructured":"Klem GH, L\u00fcders HO, Jasper HH, Elger C. The ten-twenty electrode system of the International Federation. Electroencephalogr Clin Neurophysiol. 1999;10(2):371\u20135. https:\/\/doi.org\/10.1016\/0013-4694(58)90053-1.","journal-title":"Electroencephalogr Clin Neurophysiol"},{"issue":"4","key":"720_CR26","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1007\/s10309-018-0216-8","volume":"31","author":"RS Fisher","year":"2018","unstructured":"Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the International League Against Epilepsy: position paper of the ILAE Commission for Classification and Terminology. Z Epileptol. 2018;31(4):272\u201381. https:\/\/doi.org\/10.1007\/s10309-018-0216-8.","journal-title":"Z Epileptol"},{"key":"720_CR27","doi-asserted-by":"publisher","first-page":"e296","DOI":"10.1371\/journal.pmed.0040296","volume":"4","author":"E von Elm","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Medicine. 2007;4:e296. https:\/\/doi.org\/10.1371\/journal.pmed.0040296.","journal-title":"PLoS Medicine."},{"issue":"4","key":"720_CR28","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1111\/epi.13709","volume":"58","author":"E Scheffer","year":"2017","unstructured":"Scheffer E, Berkovic S, Capovilla G, et al. Classificazione delle epilessie della International League Against Epilepsy: position paper della Commissione ILAE per la Classificazione e la Terminologia. Epilepsia. 2017;58(4):512\u201321. https:\/\/doi.org\/10.1111\/epi.13709.","journal-title":"Epilepsia."},{"key":"720_CR29","doi-asserted-by":"publisher","first-page":"2112","DOI":"10.1111\/j.1528-1167.2011.03266.x","volume":"52","author":"A Strzelczyk","year":"2011","unstructured":"Strzelczyk A, Adjei P, Scott CA, et al. Postictal increase in T-wave alternans after generalized tonic-clonic seizures. Epilepsia. 2011;52:2112\u20137. https:\/\/doi.org\/10.1111\/j.1528-1167.2011.03266.x.","journal-title":"Epilepsia."},{"issue":"11","key":"720_CR30","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1111\/epi.13131","volume":"56","author":"LL Bancke","year":"2015","unstructured":"Bancke LL, Dworak HA, Rodvold KA, Halvorsen MB, Gidal BE. Pharmacokinetics, pharmacodynamics, and safety of USL261, a midazolam formulation optimized for intranasal delivery, in a randomized study with healthy volunteers. Epilepsia. 2015;56(11):1723\u201331. https:\/\/doi.org\/10.1111\/epi.13131.","journal-title":"Epilepsia."},{"issue":"5","key":"720_CR31","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1046\/j.1365-2125.2002.01588.x","volume":"53","author":"PD Knoester","year":"2002","unstructured":"Knoester PD, Jonker DM, Van Der Hoeven RTM, et al. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers. Br J Clin Pharmacol. 2002;53(5):501\u20137. https:\/\/doi.org\/10.1046\/j.1365-2125.2002.01588.x.","journal-title":"Br J Clin Pharmacol."},{"issue":"6","key":"720_CR32","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1111\/j.1528-1167.2009.02397.x","volume":"51","author":"P Kwan","year":"2010","unstructured":"Kwan P, Arzimanoglou A, Berg AT, et al. Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies. Epilepsia. 2010;51(6):1069\u201377. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02397.x.","journal-title":"Epilepsia."},{"issue":"3","key":"720_CR33","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/j.1528-1167.2009.02333.x","volume":"51","author":"G De Haan","year":"2010","unstructured":"De Haan G, Van Der Geest P, Doelman G, Bertram E, Edelbroek P. A comparison of midazolam nasal spray and diazepam rectal solution for the residential treatment of seizure exacerbations. Epilepsia. 2010;51(3):478\u201382. https:\/\/doi.org\/10.1111\/j.1528-1167.2009.02333.x.","journal-title":"Epilepsia"},{"key":"720_CR34","doi-asserted-by":"publisher","DOI":"10.1111\/epi.15159","author":"K Detyniecki","year":"2019","unstructured":"Detyniecki K, Van Ess PJ, Sequeira DJ, Wheless JW, Meng TC, Pullman WE. Safety and efficacy of midazolam nasal spray in the outpatient treatment of patients with seizure clusters\u2014a randomized, double-blind, placebo-controlled trial. Epilepsia. 2019;60:1797\u2013808. https:\/\/doi.org\/10.1111\/epi.15159.","journal-title":"Epilepsia"},{"issue":"2","key":"720_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0172750","volume":"12","author":"LN Gonzalez Castro","year":"2017","unstructured":"Gonzalez Castro LN, Mehta JH, Brayanov JB, Mullen GJ. Quantification of respiratory depression during pre-operative administration of midazolam using a non-invasive respiratory volume monitor. PLoS One. 2017;12(2):1\u201311. https:\/\/doi.org\/10.1371\/journal.pone.0172750.","journal-title":"PLoS One"},{"issue":"2","key":"720_CR36","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1535-7597.2004.42001.x","volume":"4","author":"O Devinsky","year":"2004","unstructured":"Devinsky O. Effects of seizures on autonomic and cardiovascular function. Epilepsy Curr. 2004;4(2):43\u20136.","journal-title":"Epilepsy Curr."},{"issue":"March","key":"720_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fneur.2019.00166","volume":"10","author":"L Vilella","year":"2019","unstructured":"Vilella L, Lacuey N, Hampson JP, et al. Incidence, recurrence, and risk factors for peri-ictal central apnea and sudden unexpected death in epilepsy. Front Neurol. 2019;10:1\u201313. https:\/\/doi.org\/10.3389\/fneur.2019.00166.","journal-title":"Front Neurol."},{"issue":"3","key":"720_CR38","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1111\/epi.14006","volume":"59","author":"N Lacuey","year":"2018","unstructured":"Lacuey N, Zonjy B, Hampson JP, et al. The incidence and significance of periictal apnea in epileptic seizures. Epilepsia. 2018;59(3):573\u201382. https:\/\/doi.org\/10.1111\/epi.14006.","journal-title":"Epilepsia."},{"issue":"12","key":"720_CR39","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1093\/brain\/awn277","volume":"131","author":"LM Bateman","year":"2008","unstructured":"Bateman LM, Li CS, Seyal M. Ictal hypoxemia in localization-related epilepsy: analysis of incidence, severity and risk factors. Brain. 2008;131(12):3239\u201345. https:\/\/doi.org\/10.1093\/brain\/awn277.","journal-title":"Brain"},{"issue":"6","key":"720_CR40","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/j.rmed.2013.02.004","volume":"107","author":"ED Chan","year":"2013","unstructured":"Chan ED, Chan MM, Chan MM. Pulse oximetry: understanding its basic principles facilitates appreciation of its limitations. Respir Med. 2013;107(6):789\u201399. https:\/\/doi.org\/10.1016\/j.rmed.2013.02.004.","journal-title":"Respir Med"},{"key":"720_CR41","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.seizure.2020.02.008","volume":"76","author":"K Mahr","year":"2020","unstructured":"Mahr K, Bergmann MP, Kay L, et al. Prone, lateral, or supine positioning at seizure onset determines the postictal body position: A multicenter video-EEG monitoring cohort study. Seizure. 2020;76:173\u20138. https:\/\/doi.org\/10.1016\/j.seizure.2020.02.008.","journal-title":"Seizure."},{"issue":"3","key":"720_CR42","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/00000542-198503000-00017","volume":"62","author":"J Reves","year":"1985","unstructured":"Reves J, Fragen R, Vinik H, Greenblatt D. Midazolam: pharmacology and uses. Anesthesiology. 1985;62(3):310\u201324.","journal-title":"Anesthesiology"},{"issue":"1","key":"720_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.jemermed.2017.01.020","volume":"53","author":"AM Bailey","year":"2017","unstructured":"Bailey AM, Baum RA, Horn K, et al. Review of intranasally administered medications for use in the emergency department. J Emerg Med. 2017;53(1):38\u201348. https:\/\/doi.org\/10.1016\/j.jemermed.2017.01.020.","journal-title":"J Emerg Med"},{"key":"720_CR44","unstructured":"U.S. Food and Drug Administration. NAYZILAM\u00ae (midazolam) nasal spray CIV US Prescribing Information. 2019:1\u201323. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2019\/211321s000lbl.pdf."},{"key":"720_CR45","unstructured":"U.S. Food and Drug Administration.VALTOCO\u00ae (diazepam nasal spray), CIV US Precribing Information. 2020;1\u201328. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/211635s000lbl.pdf."},{"key":"720_CR46","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.neuropharm.2013.06.002","volume":"73","author":"A Dhir","year":"2013","unstructured":"Dhir A, Zolkowska D, Rogawski MA. Seizure protection by intrapulmonary delivery of midazolam in mice. Neuropharmacology. 2013;73:425\u201331. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.06.002.","journal-title":"Neuropharmacology"},{"issue":"February","key":"720_CR47","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/epi.14479","volume":"59","author":"PD Maglalang","year":"2018","unstructured":"Maglalang PD, Rautiola D, Siegel RA, et al. Rescue therapies for seizure emergencies: new modes of administration. Epilepsia. 2018;59:207\u201315. https:\/\/doi.org\/10.1111\/epi.14479.","journal-title":"Epilepsia"}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-020-00720-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40263-020-00720-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-020-00720-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T00:15:35Z","timestamp":1616717735000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40263-020-00720-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,26]]},"references-count":47,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["720"],"URL":"https:\/\/doi.org\/10.1007\/s40263-020-00720-w","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,26]]},"assertion":[{"value":"26 March 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"This study was supported by a LOEWE Grant from the State of Hessen for the \u201cCenter for Personalized Translational Epilepsy Research\u201d (CePTER), Goethe-University Frankfurt, Frankfurt am Main, Germany. There is no industry funding to report. Open Access funding provided by Projekt DEAL.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"AvB, SF, EH, and \u00dcB do not report any conflicts of interest. LK reports non-financial support from Eisai and UCB. SK reports honoraria for speaking engagements from Desitin and UCB as well as educational grants from AD Tech, Desitin Arzneimittel, Eisai, GW, Medtronic, Novartis, Siemens, and UCB. JPZ reports a speaker\u2019s honorarium from Eisai. PSR reports speaking honoraria from Eisai and honoraria from Austrian Institute of Technology (AIT). SSB reports personal fees from UCB Pharma, Eisai, Desitin Pharma, LivaNova, and Zogenix. FR reports personal fees from Eisai, grants and personal fees from UCB, grants and personal fees from Desitin Pharma, personal fees and other from Novartis, personal fees from Medtronic, personal fees from Cerbomed, personal fees from ViroPharma and Shire, grants from the European Union, and grants from the Deutsche Forschungsgemeinschaft. AS reports personal fees and grants from Arvelle Therapeutics, Desitin Arzneimittel, Eisai, GW Pharmaceuticals, LivaNova, Marinus Pharmaceuticals, Medtronic, Sage Therapeutics, UCB Pharma, and Zogenix.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the ethics committee of the Goethe-University Frankfurt in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived by the ethics committee of the Goethe-University Frankfurt due to the retrospective nature of this study.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}